2023-08-03 13:26:59 ET
- Eloxx Pharmaceuticals Inc. ( NASDAQ: ELOX ) on Thursday said it has been granted extension by Nasdaq to regain compliance with the listing rule.
- The listing rule requires a listed company to have at least $35 million in market value of listed securities in order to qualify for continued listing.
- The company already disclosed that on April 11, Nasdaq notified that it will delist the company’s shares as it did not comply with the listing requirements, following which Eloxx submitted a request for extension and received it until October 9.
- ELOX is -8.32% to $6.5.
- Source: Press Release
For further details see:
Eloxx Pharmaceuticals granted extension by Nasdaq to regain listing compliance